Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection

Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerab...

Full description

Saved in:
Bibliographic Details
Published inmBio Vol. 10; no. 6
Main Authors de Araujo, Leonardo Silva, Ribeiro-Alves, Marcelo, Leal-Calvo, Thyago, Leung, Janaína, Durán, Verónica, Samir, Mohamed, Talbot, Steven, Tallam, Aravind, Mello, Fernanda Carvalho de Queiroz, Geffers, Robert, Saad, Maria Helena Féres, Pessler, Frank
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 03.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB ( n  = 8), latent TB infection (LTBI; n  = 21), and treated LTBI (LTBItt; n  = 6) and in uninfected exposed controls (ExC; n  = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like ( P  = 0.03) but not M1-like ( P  = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB. IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.
AbstractList In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (  = 8), latent TB infection (LTBI;  = 21), and treated LTBI (LTBItt;  = 6) and in uninfected exposed controls (ExC;  = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of infection on chest radiographs. SNORD104 expression decreased during infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (  = 0.03) but not M1-like (  = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB. Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.
In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (P = 0.03) but not M1-like (P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (P = 0.03) but not M1-like (P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.
Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB ( n  = 8), latent TB infection (LTBI; n  = 21), and treated LTBI (LTBItt; n  = 6) and in uninfected exposed controls (ExC; n  = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like ( P  = 0.03) but not M1-like ( P  = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB. IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.
Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB ( n  = 8), latent TB infection (LTBI; n  = 21), and treated LTBI (LTBItt; n  = 6) and in uninfected exposed controls (ExC; n  = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like ( P  = 0.03) but not M1-like ( P  = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.
ABSTRACT In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (P = 0.03) but not M1-like (P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB. IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.
Author Leal-Calvo, Thyago
Mello, Fernanda Carvalho de Queiroz
Durán, Verónica
Pessler, Frank
Talbot, Steven
Ribeiro-Alves, Marcelo
Leung, Janaína
Samir, Mohamed
Geffers, Robert
Saad, Maria Helena Féres
de Araujo, Leonardo Silva
Tallam, Aravind
Author_xml – sequence: 1
  givenname: Leonardo Silva
  surname: de Araujo
  fullname: de Araujo, Leonardo Silva
  organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil, Helmholtz Centre for Infection Research, Braunschweig, Germany
– sequence: 2
  givenname: Marcelo
  surname: Ribeiro-Alves
  fullname: Ribeiro-Alves, Marcelo
  organization: Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
– sequence: 3
  givenname: Thyago
  surname: Leal-Calvo
  fullname: Leal-Calvo, Thyago
  organization: Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
– sequence: 4
  givenname: Janaína
  surname: Leung
  fullname: Leung, Janaína
  organization: Thoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
– sequence: 5
  givenname: Verónica
  surname: Durán
  fullname: Durán, Verónica
  organization: Institute for Experimental Infection Research, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany
– sequence: 6
  givenname: Mohamed
  surname: Samir
  fullname: Samir, Mohamed
  organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Department of Zoonoses, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
– sequence: 7
  givenname: Steven
  surname: Talbot
  fullname: Talbot, Steven
  organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany
– sequence: 8
  givenname: Aravind
  surname: Tallam
  fullname: Tallam, Aravind
  organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany
– sequence: 9
  givenname: Fernanda Carvalho de Queiroz
  surname: Mello
  fullname: Mello, Fernanda Carvalho de Queiroz
  organization: Thoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
– sequence: 10
  givenname: Robert
  surname: Geffers
  fullname: Geffers, Robert
  organization: Helmholtz Centre for Infection Research, Braunschweig, Germany
– sequence: 11
  givenname: Maria Helena Féres
  surname: Saad
  fullname: Saad, Maria Helena Féres
  organization: Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil
– sequence: 12
  givenname: Frank
  surname: Pessler
  fullname: Pessler, Frank
  organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Helmholtz Centre for Infection Research, Braunschweig, Germany, Centre for Individualised Infection Medicine, Hannover, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31796535$$D View this record in MEDLINE/PubMed
BookMark eNp1ksFu1DAQhiNUREvpkSvykUtKbMeJfUHaVkBXWkq1wNmyncnWJbEX21mpT8Lr4uyWiiIxF4_Gv78Zz8zL4sh5B0XxGlfnGBP-bryw_rzCFW1LLJ4VJwSzqmwZxkez3-CSYCKOi7MY76pslGJOqxfFMcWtaBhlJ8WvNWyD3wQ1jtZtkO_R11ENA7r2zvhuDq2vF-jGb6dBJetdRNahGwh2ewtBDehi8L5Da9iBGiK68jGhXNOowg8IEfU-oJVK4BJSrkMLk-wO0Od747UyKVOmEaVJQzDT4KONaOl6MHOeV8XzPhPh7OE8Lb5__PDt8qpcffm0vFysSlMzmsrWkEa3BhqhhCDAKmIY6bTOfTDZsgu90R1hhre8Bi1Y22AKCjRtFChOT4vlgdt5dSe3webS76VXVu4DPmykCsmaAWRX15zxmmOAruZKq4ZpxhrVdwCi0ZBZ7w-s7aRH6Ez-dm7RE-jTG2dv5cbvZMNFJXibAW8fAMH_nCAmOdpoYBiUAz9FSWgealMxSrL0zd-5HpP8mWwWlAeBCT7GAP2jBFdyXh45L4_cL4_EIuvpP3pj037kuVQ7_OfVb1STzWA
CitedBy_id crossref_primary_10_1128_mSystems_00163_21
crossref_primary_10_1186_s12964_024_01724_5
crossref_primary_10_1016_j_ijtb_2023_03_023
crossref_primary_10_1016_j_fmre_2023_03_003
crossref_primary_10_1016_j_micres_2020_126674
crossref_primary_10_3389_fcimb_2022_1009901
crossref_primary_10_3389_fimmu_2022_1027472
crossref_primary_10_3390_microorganisms11030626
crossref_primary_10_22207_JPAM_18_1_40
crossref_primary_10_3389_fcimb_2022_850279
crossref_primary_10_3389_fmicb_2021_808250
crossref_primary_10_1016_j_jiph_2021_06_002
crossref_primary_10_1016_j_ebiom_2022_104110
crossref_primary_10_3390_sym13071307
crossref_primary_10_1111_jcmm_15903
crossref_primary_10_1016_j_ijbiomac_2024_132714
crossref_primary_10_3390_cells9102160
crossref_primary_10_3390_ijms21196979
crossref_primary_10_5493_wjem_v15_i1_97460
crossref_primary_10_1186_s12931_024_02988_8
crossref_primary_10_1186_s12931_023_02367_9
crossref_primary_10_3389_fphar_2023_1152915
crossref_primary_10_2147_IDR_S504632
crossref_primary_10_1016_j_diagmicrobio_2024_116172
crossref_primary_10_3390_ijms23084430
crossref_primary_10_1186_s40779_024_00553_4
crossref_primary_10_1002_wsbm_1643
crossref_primary_10_15406_jmen_2022_10_00368
crossref_primary_10_1021_acschembio_3c00251
crossref_primary_10_3390_tropicalmed8020089
Cites_doi 10.1371/journal.pone.0081076
10.1042/bse0540079
10.1016/s0092-8674(02)00718-3
10.1084/jem.178.6.2249
10.1111/j.1574-6976.2012.00331.x
10.1111/jcmm.14093
10.1002/jemt.1090
10.1056/NEJMoa0907847
10.1093/nar/gkq1355
10.1038/nrg3074
10.1186/1471-2180-14-37
10.1016/j.tube.2018.10.009
10.1111/jcmm.12205
10.7326/0003-4819-149-3-200808050-00241
10.1093/bioinformatics/btw660
10.1093/bioinformatics/bts635
10.1186/s12859-018-2047-z
10.1164/ajrccm.161.4.16141
10.1155/2011/814943
10.3389/fmicb.2018.00602
10.1128/CMR.00021-18
10.1186/1471-2164-7-142
10.1371/journal.pone.0075145
10.1016/j.tube.2013.08.004
10.1038/nrm3359
10.1016/S0378-3758(02)00388-9
10.3389/fvets.2016.00022
10.1038/nrdp.2016.76
10.1371/journal.pone.0088909
10.18388/abp.2016_1330
10.1371/journal.pone.0129744
10.3390/biom8040106
10.1093/bioinformatics/btm254
10.1111/imj.12638
10.1093/bioinformatics/btt656
10.14806/ej.17.1.200
10.1093/nar/gkv468
10.1159/000496749
10.1080/2159256X.2015.1086502
10.1373/clinchem.2015.239459
10.1093/infdis/jiu612
10.1186/1471-2164-12-64
10.1183/09031936.00221214
10.1016/j.tim.2018.10.011
10.1006/meth.2001.1262
10.3389/fmicb.2016.01586
10.1093/bioinformatics/btg405
10.1371/journal.pone.0080149
10.1093/nar/gkv954
10.1186/s13059-014-0550-8
10.1371/journal.pmed.1002814
10.1172/jci.insight.87238
10.1183/09031936.00221514
10.3390/genes8120366
10.1155/2015/206849
10.1126/science.1203919
10.1038/nm.4161
10.1093/nar/gkw345
10.1093/nar/gky310
10.1128/mBio.01187-15
10.1038/nri.2016.40
10.32614/RJ-2016-042
10.1002/0471722146
10.1016/j.surg.2015.04.025
10.1093/nar/gkg849
10.1038/nri.2017.69
10.1038/nbt.3682
10.7150/ijbs.13805
10.1128/CVI.00726-13
10.1186/s12864-018-4785-8
10.1093/biostatistics/4.2.249
ContentType Journal Article
Copyright Copyright © 2019 de Araujo et al.
Copyright © 2019 de Araujo et al. 2019 de Araujo et al.
Copyright_xml – notice: Copyright © 2019 de Araujo et al.
– notice: Copyright © 2019 de Araujo et al. 2019 de Araujo et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1128/mBio.01037-19
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Profiling of the Host sncRNAome in Tuberculosis
EISSN 2150-7511
ExternalDocumentID oai_doaj_org_article_d44858481eed48aba65b556afdee96be
PMC6890987
31796535
10_1128_mBio_01037_19
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: ;
– fundername: ;
  grantid: iMed
– fundername: ;
  grantid: Science without borders program
GroupedDBID ---
0R~
53G
5VS
AAFWJ
AAGFI
AAUOK
AAYXX
ADBBV
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
CITATION
DIK
E3Z
EBS
EJD
FRP
GROUPED_DOAJ
GX1
H13
HYE
HZ~
KQ8
M48
O5R
O5S
O9-
OK1
P2P
PGMZT
RHI
RNS
RPM
RSF
CGR
CUY
CVF
ECM
EIF
M~E
NPM
RHF
7X8
5PM
ID FETCH-LOGICAL-c453t-7c26b7ce69a992e502c52dbb150cccc2dbefcbd25c8784eb957613eaeb36aea83
IEDL.DBID M48
ISSN 2161-2129
2150-7511
IngestDate Wed Aug 27 01:14:57 EDT 2025
Thu Aug 21 17:56:27 EDT 2025
Fri Jul 11 12:38:32 EDT 2025
Wed Feb 19 02:30:07 EST 2025
Tue Jul 01 01:52:42 EDT 2025
Thu Apr 24 23:08:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords subclinical tuberculosis
RNA
biosignature
sncRNA
biomarkers
transcriptome
piRNA
tuberculosis
miRNA
snRNA
snoRNA
incipient tuberculosis
Language English
License Copyright © 2019 de Araujo et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c453t-7c26b7ce69a992e502c52dbb150cccc2dbefcbd25c8784eb957613eaeb36aea83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/d44858481eed48aba65b556afdee96be
PMID 31796535
PQID 2321660532
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_d44858481eed48aba65b556afdee96be
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6890987
proquest_miscellaneous_2321660532
pubmed_primary_31796535
crossref_primary_10_1128_mBio_01037_19
crossref_citationtrail_10_1128_mBio_01037_19
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20191203
PublicationDateYYYYMMDD 2019-12-03
PublicationDate_xml – month: 12
  year: 2019
  text: 20191203
  day: 3
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle mBio
PublicationTitleAlternate mBio
PublicationYear 2019
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_28_2
e_1_3_2_41_2
e_1_3_2_64_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_62_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_68_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_66_2
e_1_3_2_60_2
e_1_3_2_9_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_54_2
e_1_3_2_75_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_52_2
e_1_3_2_73_2
e_1_3_2_5_2
e_1_3_2_33_2
e_1_3_2_58_2
e_1_3_2_79_2
e_1_3_2_3_2
e_1_3_2_14_2
e_1_3_2_35_2
e_1_3_2_56_2
e_1_3_2_50_2
e_1_3_2_71_2
e_1_3_2_27_2
e_1_3_2_48_2
e_1_3_2_29_2
e_1_3_2_40_2
e_1_3_2_65_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_63_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_69_2
e_1_3_2_25_2
e_1_3_2_46_2
e_1_3_2_67_2
e_1_3_2_61_2
e_1_3_2_80_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_17_2
e_1_3_2_59_2
e_1_3_2_6_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_76_2
e_1_3_2_32_2
e_1_3_2_51_2
e_1_3_2_74_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_57_2
Haunsberger SJ (e_1_3_2_72_2) 2017; 33
e_1_3_2_4_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_55_2
e_1_3_2_78_2
e_1_3_2_2_2
Maechler M (e_1_3_2_77_2) 2019
Liu A (e_1_3_2_12_2) 2009; 2
e_1_3_2_70_2
References_xml – ident: e_1_3_2_57_2
  doi: 10.1371/journal.pone.0081076
– ident: e_1_3_2_21_2
  doi: 10.1042/bse0540079
– ident: e_1_3_2_20_2
  doi: 10.1016/s0092-8674(02)00718-3
– ident: e_1_3_2_47_2
  doi: 10.1084/jem.178.6.2249
– ident: e_1_3_2_5_2
  doi: 10.1111/j.1574-6976.2012.00331.x
– ident: e_1_3_2_54_2
  doi: 10.1111/jcmm.14093
– ident: e_1_3_2_28_2
  doi: 10.1002/jemt.1090
– ident: e_1_3_2_9_2
  doi: 10.1056/NEJMoa0907847
– ident: e_1_3_2_24_2
  doi: 10.1093/nar/gkq1355
– ident: e_1_3_2_49_2
– ident: e_1_3_2_17_2
  doi: 10.1038/nrg3074
– ident: e_1_3_2_52_2
  doi: 10.1186/1471-2180-14-37
– ident: e_1_3_2_43_2
  doi: 10.1016/j.tube.2018.10.009
– ident: e_1_3_2_53_2
  doi: 10.1111/jcmm.12205
– ident: e_1_3_2_7_2
  doi: 10.7326/0003-4819-149-3-200808050-00241
– volume: 33
  start-page: 592
  year: 2017
  ident: e_1_3_2_72_2
  article-title: miRNAmeConverter: an R/bioconductor package for translating mature miRNA names to different miRBase versions
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btw660
– ident: e_1_3_2_62_2
  doi: 10.1093/bioinformatics/bts635
– ident: e_1_3_2_65_2
  doi: 10.1186/s12859-018-2047-z
– ident: e_1_3_2_30_2
  doi: 10.1164/ajrccm.161.4.16141
– ident: e_1_3_2_2_2
  doi: 10.1155/2011/814943
– ident: e_1_3_2_15_2
  doi: 10.3389/fmicb.2018.00602
– ident: e_1_3_2_46_2
  doi: 10.1128/CMR.00021-18
– ident: e_1_3_2_76_2
  doi: 10.1186/1471-2164-7-142
– ident: e_1_3_2_39_2
– ident: e_1_3_2_51_2
  doi: 10.1371/journal.pone.0075145
– ident: e_1_3_2_14_2
  doi: 10.1016/j.tube.2013.08.004
– ident: e_1_3_2_35_2
  doi: 10.1038/nrm3359
– ident: e_1_3_2_78_2
  doi: 10.1016/S0378-3758(02)00388-9
– ident: e_1_3_2_10_2
  doi: 10.3389/fvets.2016.00022
– ident: e_1_3_2_4_2
  doi: 10.1038/nrdp.2016.76
– ident: e_1_3_2_55_2
  doi: 10.1371/journal.pone.0088909
– ident: e_1_3_2_38_2
  doi: 10.18388/abp.2016_1330
– ident: e_1_3_2_40_2
  doi: 10.1371/journal.pone.0129744
– volume: 2
  start-page: 519
  year: 2009
  ident: e_1_3_2_12_2
  article-title: MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues
  publication-title: Int J Clin Exp Pathol
– ident: e_1_3_2_60_2
– ident: e_1_3_2_34_2
  doi: 10.3390/biom8040106
– ident: e_1_3_2_67_2
  doi: 10.1093/bioinformatics/btm254
– ident: e_1_3_2_37_2
  doi: 10.1111/imj.12638
– ident: e_1_3_2_63_2
  doi: 10.1093/bioinformatics/btt656
– ident: e_1_3_2_61_2
  doi: 10.14806/ej.17.1.200
– ident: e_1_3_2_75_2
  doi: 10.1093/nar/gkv468
– ident: e_1_3_2_50_2
  doi: 10.1159/000496749
– ident: e_1_3_2_45_2
  doi: 10.1080/2159256X.2015.1086502
– ident: e_1_3_2_25_2
  doi: 10.1373/clinchem.2015.239459
– year: 2019
  ident: e_1_3_2_77_2
  article-title: cluster: cluster analysis basics and extensions
  publication-title: R package version 2.1.0
– ident: e_1_3_2_36_2
  doi: 10.1093/infdis/jiu612
– ident: e_1_3_2_68_2
– ident: e_1_3_2_71_2
  doi: 10.1186/1471-2164-12-64
– ident: e_1_3_2_23_2
  doi: 10.1183/09031936.00221214
– ident: e_1_3_2_13_2
  doi: 10.1016/j.tim.2018.10.011
– ident: e_1_3_2_73_2
  doi: 10.1006/meth.2001.1262
– ident: e_1_3_2_31_2
  doi: 10.3389/fmicb.2016.01586
– ident: e_1_3_2_70_2
  doi: 10.1093/bioinformatics/btg405
– ident: e_1_3_2_3_2
– ident: e_1_3_2_58_2
  doi: 10.1371/journal.pone.0080149
– ident: e_1_3_2_80_2
– ident: e_1_3_2_19_2
  doi: 10.1093/nar/gkv954
– ident: e_1_3_2_64_2
  doi: 10.1186/s13059-014-0550-8
– ident: e_1_3_2_8_2
  doi: 10.1371/journal.pmed.1002814
– ident: e_1_3_2_32_2
  doi: 10.1172/jci.insight.87238
– ident: e_1_3_2_16_2
  doi: 10.1183/09031936.00221514
– ident: e_1_3_2_18_2
  doi: 10.3390/genes8120366
– ident: e_1_3_2_22_2
  doi: 10.1155/2015/206849
– ident: e_1_3_2_42_2
  doi: 10.1126/science.1203919
– ident: e_1_3_2_48_2
  doi: 10.1038/nm.4161
– ident: e_1_3_2_66_2
  doi: 10.1093/nar/gkw345
– ident: e_1_3_2_74_2
  doi: 10.1093/nar/gky310
– ident: e_1_3_2_44_2
  doi: 10.1128/mBio.01187-15
– ident: e_1_3_2_11_2
  doi: 10.1038/nri.2016.40
– ident: e_1_3_2_79_2
  doi: 10.32614/RJ-2016-042
– ident: e_1_3_2_41_2
  doi: 10.1002/0471722146
– ident: e_1_3_2_29_2
  doi: 10.1016/j.surg.2015.04.025
– ident: e_1_3_2_33_2
  doi: 10.1093/nar/gkg849
– ident: e_1_3_2_6_2
  doi: 10.1038/nri.2017.69
– ident: e_1_3_2_26_2
  doi: 10.1038/nbt.3682
– ident: e_1_3_2_56_2
  doi: 10.7150/ijbs.13805
– ident: e_1_3_2_59_2
  doi: 10.1128/CVI.00726-13
– ident: e_1_3_2_27_2
  doi: 10.1186/s12864-018-4785-8
– ident: e_1_3_2_69_2
  doi: 10.1093/biostatistics/4.2.249
SSID ssj0000331830
Score 2.403056
Snippet Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect...
In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have...
ABSTRACT In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs)...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Adult
biomarkers
Biomarkers - metabolism
biosignature
Female
Gene Expression Profiling - methods
Host-Microbe Biology
Humans
incipient tuberculosis
Latent Tuberculosis - genetics
Leukocytes, Mononuclear - metabolism
Macrophages - metabolism
Male
MicroRNAs - genetics
Middle Aged
miRNA
Mycobacterium tuberculosis - pathogenicity
piRNA
RNA
RNA, Small Untranslated - genetics
Tuberculosis - genetics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA6yIPgi3p11lQjik3Xb5tLkcUZcRnGHZXVh30puxYE2lWkr7C_Zv-tJ2hlmRPHFPpU2tCH5cs53yMl3EHpDdBD9sDaxzKQJBUwkwhQ60SYnslImy-Ip1_MVX17Rz9fseq_UV8gJG-WBx4E7tRA_sKD5DsacCqUVZ5oxrirrnOTaBesLPm8vmIo2mASspltRzVycNot1-z6Np-KCqs6eE4pa_X8imL_nSe45nrMH6P7EGPF87OlDdMf5R-juWEPy5jG6BQo95lg14IVwW-GvjaprvGq9aYNjwperOb7Y1enq8NrjC8Bd1BOo8SJkruNL9xMYY4eXbddj-HYTsnY2HQZKi78AHfU9Vt7iebSO-PzGgBmIMs9Dg_tBu40Z6rZbd_jTlNzln6Crs4_fPiyTqdpCYigjfVKYnOvCOC6VlLljaW5YbrUGxmjggltXGW1zZkQhqNMSIpWMOAXROFdOCfIUHfnWu-cIV0w4UyiaUusoqZiylaB5ISstqCasmKF32-EvzSRFHipi1GUMSXJRhtkq42yVmZyht7vmP0YNjr81XIS53DUK0tnxAQCqnABV_gtQM_R6i4QSllrYP1HetUNXAvnMOA-lNGbo2YiM3a-AhknOCJuh4gAzB305fOPX36OcNxcylaI4_h-df4HuAaOLBS5ScoKO-s3gXgJr6vWruEB-Ac4THNc
  priority: 102
  providerName: Directory of Open Access Journals
Title Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/31796535
https://www.proquest.com/docview/2321660532
https://pubmed.ncbi.nlm.nih.gov/PMC6890987
https://doaj.org/article/d44858481eed48aba65b556afdee96be
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFA6yIvgi3q2XJYL4ZNe2uTR5EJkR11GcYVkdmLeSpKkO9KJtR5xf4t_1JO2MzrKCfSilDb3knJPznfTkOwg9I9qRfuR5mDMThRR0IhQm1aE2CZGFMnHsV7nOF3y2pB9WbPWHUmjswO7S0M7Vk1q25cnP79vXYPCvhgUw4mU1XTcnkV_w5ghAr4JTSp2Nzkek7wdl4pTXzbgkgHFCGLDljnHz4h0OPJQn8r8MfV5MovzLK53eRDdGOIkng_xvoSu2vo2uDQUmt3fQL8DXQwJWBS4KNwX-VKmyxIumNo3zWvh8McFn-yJeHV7X-AyU0pMNlHjq0trxuf0BcLLDs6brMdy7cik9bYcB7-KPgFXrHqs6xxM_dOL51sAY4TmgNxXuN9q2ZlM23brD78fMr_ouWp6-_fxmFo6lGEJDGenD1CRcp8ZyqaRMLIsSw5Jca4CTBjY4tIXRecKMSAW1WkIYExOrIFTnyipB7qGjuqntA4QLJqxJFY1obikpmMoLQZNUFlpQTVgaoBe77s_MyFPuymWUmY9XEpE5aWVeWlksA_R83_zbQNDxr4ZTJ8t9I8er7U807ZdsNNMsh2iVuQoDAB2oUFpxphnjqsitlVzbAD3daUIGduh-rqjaNpsuA2Qac-7qbATo_qAZ-0cBRpOcERag9EBnDt7l8Eq9_uq5vrmQkRTpw__9ykfoOkA6X-EiIo_RUd9u7BOATb0-9tMNsH-3io-9cfwG-1ccZQ
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reprogramming+of+Small+Noncoding+RNA+Populations+in+Peripheral+Blood+Reveals+Host+Biomarkers+for+Latent+and+Active+Mycobacterium+tuberculosis+Infection&rft.jtitle=mBio&rft.au=de+Araujo%2C+Leonardo+Silva&rft.au=Ribeiro-Alves%2C+Marcelo&rft.au=Leal-Calvo%2C+Thyago&rft.au=Leung%2C+Jana%C3%ADna&rft.date=2019-12-03&rft.issn=2161-2129&rft.eissn=2150-7511&rft.volume=10&rft.issue=6&rft_id=info:doi/10.1128%2FmBio.01037-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_mBio_01037_19
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon